Benzodiazepine self-administration in humans and laboratory animals - Implications for problems of long-term use and abuse

Psychopharmacology

Volumn 134, Issue 1, 1997, Pages 1-37

  Griffiths, Roland R ^a,b   Weerts, Elise M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Abuse; Accidents; Alcohols; Anxious subjects; Baboons; Benzodiazepine; Brain damage; Drug abusers; Drug history; Drug self administration; Elderly; Falls; Flunitrazepam; Hip fracture; Insomniacs; Long term use; Memory; Monkeys; Normal subjects; Onset; Pain; Physical dependence; Rats; Reinforcement; Sleeping problems; Social drinking; Withdrawal

Indexed keywords

ABECARNIL; ALPRAZOLAM; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CANNABIS; CHLORPROMAZINE; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; HALAZEPAM; HYPNOTIC AGENT; LORAZEPAM; METHADONE; OXAZEPAM; PENTOBARBITAL; PHENOBARBITAL; TEMAZEPAM; TRANQUILIZER; TRIAZOLAM;

AMNESIA; BABOON; BRAIN INJURY; COGNITION; DRUG ABUSE; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; DRUG USE; FALLING; HUMAN; MONKEY; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; SIDE EFFECT; SOCIAL PROBLEM; WITHDRAWAL SYNDROME;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; HUMANS; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 0030724632     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050422     Document Type: Review

References (258)

1. Allgulander C, Borg S, Vikander B (1984) A 4-6-year follow-up of 50 patients with primary dependence on sedative and hypnotic drugs. Am J Psychiatry 141: 1580-1582
2. Altshuler HL, Phillips PE (1978) Intragastric self-administration of drugs by the primate. In: Ho BT, Richards DW III, Chute DL (eds) Drug discrimination and state-dependent learning. Academic Press, New York, pp 263-280
3. Amit Z, Cohen J (1974) The effect of hypothalamic stimulation on oral ingestion in rats. Behav Biol 10: 223-229
4. Amit Z, Corcoran ME, Charness ME, Shizgal P (1973) Intake of diazepam and hashish by alcohol preferring rats deprived of alcohol. Physiol Behav 10: 523-527
5. Ashton H (1987) Benzodiazepine withdrawal: outcome in 50 patients. Br J Addict 82: 665-671
6. Ator NA, Griffiths RR (1983) Oral self-administration of methohexital in baboons. Psychopharmacology 79: 120-125
7. Ator NA, Griffiths RR (1992) Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence. Psychopharmacology 108: 301-312
8. Ator NA, Griffiths RR (1993) Differential sensitivity to midazolam discriminative-stimulus effects following self-administered versus response-independent midazolam. Psychopharmacology 110: 1-4
9. Bailly D, Georget O, Houdret N, Lhermitte M, Dervaux A, Parquet Ph J (1990) Alcoholism and drug abuse: sociodemographic and toxicologic data. Semin Hop Paris 66: 2448-2454
10. Balster RL, Woolverton WL (1982) Intravenous buspirone self-administration in rhesus monkeys. J Clin Psychiatry 43[12 Sec 2]: 34-37
11. Balter MB, Uhlenhuth EH (1992) New epidemiologic findings about insomnia and its treatment. J Clin Psychiatry 53[12. Suppl]: 34-39
12. Barnas C, Miller CH, Sperner G, Sperner-Unterweger B, Beck E, Hinterhuber H, Fleischhacker WW (1992a) The effects of alcohol and benzodiazepines on the severity of ski accidents. Acta Psychiatr Scand 86: 296-300
13. Barnas C, Rossmann M, Roessler H, Riemer Y, Fleischhacker WW (1992b) Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: Familiarity and perference. J Clin Psychopharmacol 12: 397-402
14. Barnas C, Whitworth AB, Fleischhacker WW (1993) Are patterns of benzodiazepine use predictable? Psychopharmacology 111: 301-305
15. Barrett JE, Vanover KE (1993) 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology 112: 1-12
16. Bechelli LPdeC, Navas F, Pierangelo SA (1983) Comparison of the reinforcing properties of zopiclone and triazolam in former alcoholics. Pharmacology 27 [Suppl 2]: 235-241
17. Berg RL, Cassells JS (eds) (1990) Falls in older persons - risk factors and prevention. In: The second fifty years - promoting health and preventing disability. National Academy Press, Washington, DC, pp 263-290
18. Bergman J, Johanson CE (1985) The reinforcing properties of diazepam under several conditions in the rhesus monkey. Psychopharmacology 86: 108-113
19. Bergman U, Griffiths RR (1986) Relative abuse of diazepam and oxazepam: Prescription forgeries and theft/loss reports in Sweden. Drug Alcohol Depend 16: 293-301
20. Bigelow GE, Griffiths RR, Liebson IA (1976) Effects of response requirement upon human sedative self-administration and drug-seeking behavior. Pharmacol Biochem Behav 5: 681-685
21. Boissl K, Dreyfus JF, Delmotte M (1983) Studies on the dependence-inducing potential of zopiclone and triazolam. Pharmacology 27 [Suppl 2]: 242-247
22. Branch MN (1991) Behavioral pharmacology. In: Iversen IH, Lattal KA (eds) Experimental analysis of behavior, part 2. Elsevier, Amsterdam pp 21-77
23. Busto U, Simpkins J, Sellers EM, Sisson B, Segal R (1983) Objective determination of benzodiazepine use and abuse in alcoholics. Br J Addict 78: 429-435
24. Busto U, Sellers EM, Naranjo CA, Cappell H, Sanchez-Craig M. Sykora K (1986) Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 315: 854-859
25. Busto UE, Romach MK, Sellers EM (1996a) Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. J Clin Psychopharmacol 16: 51-57
26. Busto UE, Ruiz I, Busto M, Gacitúa A (1996b) Benzodiazepine use in Chile: impact on availability on use, abuse, and dependence. J Clin Psychopharmacol 16: 363-372
27. Cahalan D, Cisin IM, Crossley HM (1969) American drinking practices: a national study of drinking behavior and attitudes. Rutgers Center of Alcohol Studies, Monograph 6, New Brunswick, N.J.
28. Cantopher T, Olivieri S, Cleave N, Edwards JG (1990) Chronic benzodiazepine dependence - a comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal. Br J Psychiatry 156: 406-411
29. Cappell H, Busto U, Kay G, Naranjo CA, Sellers EM, Sanchez-Craig M (1987) Drug deprivation and reinforcement by diazepam in a dependent population. Psychopharmacology 91: 154-160
30. Catania AC (1991) Glossary. In: Iversen IH, Lattal KA (eds) Experimental analysis of behavior, part 2, volume 6 of series, techniques in the behavioral and neural sciences. Elsevier, Amsterdam, pp G1-G44
31. Chutuape MAD, de Wit H (1994) Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug Alcohol Depend 34: 243-251
32. Chutuape MAD, de Wit H (1995) Preferences for ethanol and diazepam in anxious individuals: an evaluation of the self-medication hypothesis. Psychopharmacology 121: 91-103
33. Ciraulo DA, Barnhill JG, Greenblatt DJ, Shader RI, Ciraulo AM, Tarmey MF, Molloy MA, Foti ME (1988a) Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry 49: 333-337
34. Ciraulo DA, Sands BF, Shader RI (1988b) Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry 145: 1501-1506
35. Collins RJ, Weeks JR, Cooper MM, Good PI, Russell RR (1984) Prediction of abuse liability of drugs using I.V. self-administration by rats. Psychopharmacology 82: 6-13
36. Crane M, Sereny G, Gordis E (1988) Drug use among alcoholism detoxification patients: prevalence and impact on alcoholism treatment. Drug Alcohol Depend 22: 33-36
37. Csernansky JG, Newcomer JG (1995) Maintenance drug treatment for schizophrenia. In: Bloom FE, Kupher DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1267-1275
38. Cumming RG, Klineberg RJ (1993) Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust 158: 414-417
39. Cumming RG, Miller JP, Kelsey JL, Davis P, Arfken CL, Birge SJ, Peck WA (1991) Medications and multiple falls in elderly people: the St Louis study. Age Aging 20: 455-461
40. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. N Engl J Med 332: 767-773
41. Curran HV (1991) Benzodiazepines, memory and mood: a review. Psychopharmacology 105: 1-8
42. Curran HV (1992) Memory functions, alertness and mood of long-term benzodiazepine users: a preliminary investigation of the effects of a normal daily dose. J Psychopharmacol 6: 69-75
43. Cwikel J (1992) Falls among elderly people living at home: medical and social factors in a national sample. Isr J Med Sci 28: 446-453
44. Darke S (1994) Benzodiazepine use among injecting drug users: problems and implications. Addiction 89: 379-382
45. Darke S, Hall W, Ross M, Wodak A (1992) Benzodiazepine use and HIV risk-taking behaviour among injecting drug users. Drug Alcohol Depend 31: 31-36
46. Darke S, Swift W, Hall W, Ross M (1993) Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend 34: 67-70
47. Darke S, Ross J, Cohen J (1994) The use of benzodiazepines among regular amphetamine users. Addiction 89: 1683-1690
48. Darke SG, Ross JE, Hall WD (1995) Benzodiazepine use among injecting heroin users. Med J Aust 162: 645-647
49. Davis MW, Smith TE, Smith SG (1987) Intravenous and intragastric self-administration of chlordiazepoxide in the rat. Alcohol Drug Res 7: 511-516
50. de la Garza R, Johanson CE (1987) The effects of food deprivation on the self-administration of psychoactive drugs. Drug Alcohol Depend 19: 17-27
51. de Wit H (1991) Diazepam preference in males with and without an alcoholic first-degree relative. Alcohol Clin Exp Res 15: 593-600
52. de Wit H, Doty P (1994) Preference for ethanol and diazepam in light and moderate social drinkers: a within-subjects study. Psychopharmacology 115: 529-538
53. de Wit H, Johanson CE, Uhlenhuth EH (1984a) Reinforcing properties of lorazepam in normal volunteers. Drug Alcohol Depend 13: 31-41
54. de Wit H, Uhlenhuth EH, Johanson CE (1984b) Lack of preference for flurazepam in normal volunteers. Pharmacol Biochem Behav 21: 865-869
55. de Wit H, Uhlenhuth EH, Johanson CE (1985) Drug preference in normal volunteers: Effects of age and time of day. Psychopharmacology 87: 186-193
56. de Wit H, Uhlenhuth EH, Hedeker D, McCracken SG, Johanson CE (1986) Lack of preference for diazepam in anxious volunteers. Arch Gen Psychiatry 43: 533-541
57. de Wit H, Pierri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers. Pharmacol Biochem Behav 33: 205-213
58. de Wit H, Bodker B, Ambre J (1992) Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacology 107: 352-358
59. de Wit H, Dudish S, Ambre J (1993) Subjective and behavioral effects of diazepam depend on its rate of onset. Psychopharmacology 112: 324-330
60. Dellemijn PLI, Fields HL (1994) Do benzodiazepines have a role in chronic pain management? Pain 57: 137-152
61. DuPont RL (ed) (1988) Abuse of benzodiazepines: the problems and the solutions. Am J Drug Alcohol Abuse 14 [Suppl 1]: 1-69
62. Evans SM, Funderburk FR, Griffiths RR (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 255: 1246-1255
63. Evans SM, Troisi JR, Griffiths RR (1994) Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans. J Pharmacol Exp Ther 271: 683-694
64. Evans SM, Griffiths RR, de Wit H (1996) Preference for diazepam, but not buspirone, in moderate drinkers. Psychopharmacology 123: 154-163
65. Fahre LF, McLendon DM, Harris RT (1976) Preference studies of triazolam with standard hypnotics in out-patients with insomnia. J Int Med Res 4: 247-254
66. Falk JL, Tang M (1985) Midazolam oral self-administration. Drug Alcohol Depend 15: 151-163
67. Falk JL, Tang M (1989a) Schedule induction of drug intake: differential responsiveness to agents with abuse potential. J Pharmacol Exp Ther 249: 143-149
68. Falk JL, Tang M (1989b) Schedule-induced chlordiazepoxide intake: differential effect of cocaine and ethanol histories. Pharmacol Biochem Behav 33: 393-396
69. Findley JD, Robinson WW, Peregrino L (1972) Addiction to secobarbital and chlordiazepoxide in the rhesus monkey by means of a self-infusion preference procedure. Psychopharmacologia 26: 93-114
70. Finlay JM, Szostak C, Fihiger HC (1989) Further characterization of IV self-administration of midazolum in the rat. Behav Pharmacol 1: 13-23
71. Fischman MW, Schuster CR (1984) Injection duration of cocaine in humans (Abstract). Fed Proc 43: 570
72. Foy A, O'Connell D, Henry D, Kelly J, Cocking S, Halliday J (1995) Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol Med Sci 50A: M99-M106
73. Fraser HF, Jasinski DR (1977) The assessment of the abuse potentiality of sedative/hypnotics (depressants): methods used in animals and man. In: Martin WR (ed) Drug addiction I. Morphine, sedative/hypnotic and alcohol dependence. Springer, Berlin, pp 589-612
74. Ghoneim MM, Mewaldt SP (1990) Benzodiazepines and human memory: a review. Anesthesiology 72: 926-938
75. Ghoneim MM, Mewaldt SP, Berie JL, Hinrichs JV (1981) Memory and performance effects of single and 3-week administration of diazepam. Psychopharmacology 73: 147-151
76. Gilbert A, Owen N, Quintrell N (1990) Trends over six years in the prescribing of benzodiazepines for residents of aged-care facilities. J Soc Admin Pharm 7: 123-129
77. Gilbert A, Owen N, Innes JM, Sansom L (1993) Trial of an intervention to reduce chronic benzodiazepine use among residents of aged-care accommodation. Aust NZJ Med 23: 343-347
78. Glennon RA, Dukat M (1995) Serotonin receptor subtypes. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 415-429
79. Goa KL, Ward A (1986) Buspirone - a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32: 114-129
80. Golombok S, Moodley P, Lader M (1988) Cognitive impairment in long-term benzodiazepine users. Psychol Med 18: 365-374
81. Gorenstein C, Bernik MA, Pompéia S, Marcourakis T (1995) Impairment of performance associated with long-term use of benzodiazepines. J Psychopharmacol 9: 313-318
82. Götestam KG (1973) Intragastric self-administration of medazepam in rats. Psychopharmacologia 28: 87-94
83. Grad RM (1995) Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk. J Fam Pract 41: 473-481
84. Grant KA, Johanson CE (1987) Diazepam self-administration and resistance to extinction. Pharmacol Biochem Behav 28: 81-86
85. Green S, Goldberg D, Frischer M, McKeganey N (1992) Triazolam as a substance of abuse among injecting drug users. Br J Addict 57: 940-941
86. Griffiths R, Ator N (1981) Benzodiazepine self-administration in animals and humans: a comprehensive literature review. In: Szara S, Ludford J (eds) Benzodiazepines: a review of research results, 1980. NIDA Research Monograph, Government Printing Office, Washington, DC, pp 22-36
87. Griffiths RR, Mumford GK (1995) Caffeine - a drug of abuse? In: Bloom FE, Kupher DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1699-1713
88. Griffiths RR, Roache JD (1985) Abuse liability of benzodiazepines: a review of human studies evaluating subjective and/or reinforcing effects. In: Smith DE, Wesson DR (eds) The benzodiazepines: current standards for medical practice. MTP Press, Lancaster, pp 209-225
89. Griffiths RR, Wolf B (1990) Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 10: 237-243
90. Griffiths RR, Bigelow GE, Liebson I (1976) Human sedative self-administration: effects of interingestion interval and dose. J Pharmacol Exp Ther 197: 488-494
91. Griffiths RR, Bigelow GE, Liebson I (1979a) Human drug self-administration: double-blind comparison of pentobarbital, diazepam, chlorpromazine and placebo. J Pharmacol Exp Ther 210: 301-310
92. Griffiths RR, Brady JV, Bradford LD (1979b) Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens. In: Thompson T, Dews P (eds) Advances in behavioral pharmacology: volume II. Academic Press, New York, pp 163-208
93. Griffiths RR, Bigelow GE, Henningfield JE (1980a) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse. JAI Press, Greenwich, Conn., pp 1-90
94. Griffiths RR, Bigelow GE, Liebson I, Kaliszak JE (1980b) Drug preference in humans: Double-blind choice comparison of pentobarbital, diazepam and placebo. J Pharmacol Exp Ther 215: 649-661
95. Griffiths RR, Lukas SE, Bradford D, Brady JV, Snell JD (1981) Self-injection of barbiturates and benzodiazepines in baboons. Psychopharmacology 75: 101-109
96. Griffiths RR, Bigelow GE, Liebson I (1983) Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry 40: 865-873
97. Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD (1984a) Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects. Psychopharmacology 84:147-154
98. Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD. Nowowieski P (1984b) Comparison of diazepam and oxazepam: preference, liking and extent of abuse. J Pharmacol Exp Ther 229: 501-508
99. Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV (1985) Relative abuse liability of triazolam: experimental assessment in animals and humans. Neurosci Biobehav Rev 9: 133-151
100. Griffiths RR, Lamb RJ, Sannerud CA, Ator NA, Brady JV (1991) Self-injection of barbiturates, benzodiazpines and other sedative-anxiolytics in baboons. Psychopharmacology 103: 154-161
101. Griffiths RR, Sannerud CA, Ator NA, Brady JV (1992) Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 260: 1199-1208
102. Hackett D, Hall JM (1977) Reinforcing properties of IV diazepam in rhesus monkeys (Macaca mulatta) with a history of codeine self-administration. In: Dincon WAM (ed) Clinical Toxicological Proceedings of the 18th Meeting of the European Society of Toxicology. Excerpta Medica, Amsterdam, pp 308-310
103. Hale WE, Stewart RB, Marks RG (1985) Antianxiety drugs and central nervous system symptoms in an ambulatory elderly population. Drug Intell Clin Pharm 19: 37-40
104. Hallström C (ed) (1993) Benzodiazepine dependence. Oxford University Press, Oxford
105. Hardo PG, Kennedy TD (1991) Night sedation and arthritic pain. J R Soc Med 84: 73-75
106. Harris RT, Claghorn JL, Schooiar JC (1968) Self administration of minor tranquilizers as a function of conditioning. Psychopharmacologia 13: 81-88
107. Healey ML, Pickens RW (1983) Diazepam dose preference in humans. Pharmacol Biochem Behav 18: 449-456
108. Hendler N, Cimmi C, Ma T, Long D (1980) A comparison of cognitive impairment due to benzodiazepines and to narcotics. Am J Psychiatry 137: 828-830
109. Henningfield JE, Lukas SE, Bigelow GE (1986) Human studies of drugs as reinforcers. In: Goldberg SR, Stolerman IP (eds) Behavioral analysis of drug dependence. Academic Press, Orlando, Fla., pp 69-122
110. Henningfield JE, Kennan RM, Clarke PBS (1996) Nicotine. In: Schuster CR, Kuhar MJ (eds) Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach (Handbook of Experimental Pharmacology; v. 118). Springer, New York, pp 271-314
111. Herings RMC, Stricker BHCh, de Boer A, Bakker A, Sturmans F (1995) Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Int Med 155: 1801-1807
112. Higgitt A, Fonagy P (1993) Benzodiazepine dependence syndromes and syndromes of withdrawal. In: Hallström C (ed) Benzodiazepine dependence. Oxford University Press, Oxford, pp 58-70
113. Hoffmeister F (1974) Positive and negative reinforcing properties of psychotropic drugs in rhesus monkeys. Neuropsychopharmacology - Proceedings of the IX Congress of the Collegium Internationale Neuropsychopharmacologicum, Paris. Excerpta Medica, Amsterdam, pp 245-252
114. Hoffmeister F (1977) Assessment of reinforcing properties of stimulant and depressant drugs in the rhesus monkey as a tool for the prediction of psychic dependence-producing capability in man. In: Thompson T, Umma KR (eds) Predicting dependence liability of stimulant and depressant drugs. University Park Press, Baltimore, pp 185-201
115. Hollister LE, Müller-Oerlinghausen B, Rickels K, Shader RI (1993) Clinical uses of benzodiazepines. J Clin Psychopharmacol 13[6; Suppl 1]: 1S-169S
116. Hughes JR (1993) Smoking is a drug dependence: a reply to Robinson and Pritchard. Psychopharmacology 113: 282-283
117. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR (1993) Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 32: 257-266
118. Jasinski DR, Haertzen CA, Henningfield JE, Johnson RE, Makhzoumi HM, Miyasato K (1982) Progress report of the NIDA Addiction Research Center. In: Harris LS (ed) Problems of drug dependence 1981: Proceedings of the 43rd Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc. NIDA Research Monograph No. 41. US Government Printing Office, Washington, D.C., pp 45-52
119. Jasinski DR, Henningfield JE, Johnson RE (1983) Progress report of the NIDA Addiction Research Center, Baltimore, Maryland, 1982. In: Harris LS (ed) Problems of drug dependence 1982: Proceedings of the 44th Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc. NIDA Research Monograph No. 43. US Government Printing Office, Washington, D.C., pp 92-98
120. Jick H, Slone D, Dinan B, Muench H (1966) Evaluation of drug efficacy by a preference technic. N Engl J Med 275: 1399-1403
121. Johanson CE (1987) Benzodiazepine self-administration in rhesus monkeys: estazolam, flurazepam and lorazepam. Pharmacol Biochem Behav 26: 521-526
122. Johanson CE, Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull Narc 30: 43-54
123. Johanson CE, de Wit H (1992) Lack of effect of social context on the reinforcing effects of diazepam in humans. Pharmacol Biochem Behav 43: 463-469
124. Johanson CE, Schuster CR (1986) The effects of Ro 15-1788 on anxiolytic self-administration in the rhesus monkey. Pharmacol Biochem Behav 24: 855-859
125. Johanson CE, Uhlenhuth EH (1980) Drug preference and mood in humans: diazepam. Psychopharmacology 71: 269-273
126. Johnston LD, O'Malley PM, Bachman JG (1993) National survey results on drug use from monitoring the future study, 1975-1992. NIDA, NIH Publication No. 93-3597. USDHHS, US Government Printing Office, Washington, D.C.
127. Kamano DK, Arp DL (1965) Chlordiazepoxide (librium) consumption under stress conditions in rats. Int J Neuropsychiatr 1: 189-192
128. Kautz MA, Ator NA (1995) Effects of triazolam on drinking in baboons with and without an oral self-administration history: a reinstatement phenomenon. Psychopharmacology 122: 108-114
129. Kautz MA, Ator NA (1996) Comparing the reinforcing efficacy of orally self-administered triazolam and alprazolam in baboons. In: Harris LS (ed) Problems of drug dependence, 1995. NIDA Research Monograph No. 162. NIH Publication No. 96-4116. US Government Printing Office, Washington D.C., p 243
130. King MB, Gabe J, Williams P, Rodrigo EK (1990) Long term use of benzodiazepines: the views of patients. Br J Gen Pract 40: 194-196
131. King SA, Strain JJ (1990a) Benzodiazepine use by chronic pain patients. Clin J Pain 6: 143-147
132. King SA, Strain JJ (1990b) Benzodiazepines and chronic pain. Pain 41: 3-4
133. Klee H, Faugier J, Hayes C, Boulton T, Morris J (1990) AIDS-related risk behaviour, polydrug use and temazepam. Br J Addict 85: 1125-1132
134. Krska J, MacLeod TNN (1995) Sleep quality and the use of benzodiazepine hypnotics in general practice. J Clin Pharmacol Ther 20: 91-96
135. Kubota A, Kuwahara A, Hakkei M, Nakamura K (1986) Drug dependence test on a new anesthesia inducer, midazolam. Folia Pharmacol Japon 88: 125-158
136. Lader MH, Ron M, Petursson H (1984) Computed axial brain tomography in long-term benzodiazepine users. Psychol Med 14: 203-206
137. Larson EB, Kukull WA, Buchner D, Reifler BV (1987) Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Int Med 107: 169-173
138. Launchbury AP, Morton FSS, Lacy JE (1989) The development of temazepam gelthix. Manufacturing Chemist, December, pp 38-40
139. Lichtenstein MJ, Griffin MR, Cornell JE, Malcolm E, Ray WA (1994) Risk factors for hip fractures occurring in the hospital. Am J Epidemiol 140[9]: 830-838
140. Lucki I, Rickels K (1988) The effect of anxiolytic drugs on memory in anxious subjects. In: Hindmarch I, Ott H (eds) Benzodiazepine receptor ligands, memory and information processing - psychometric, psychopharmacological and clinical issues. Springer, Berlin, pp 128-139
141. A/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology 34: 245-254
142. Macenski MJ, Meisch RA (1994) Oral drug reinforcement studies with laboratory animals: applications and implications for understanding drug-reinforced behavior. Curr Direct Psych Sci 3: 22-27
143. McCracken SG, de Wit H, Uhlenhuth EH, Johanson CE (1990) Preference for diazepam in anxious adults. J Clin Psychopharmacol 10: 190-196
144. Meisch RA, Lemaire GA (1993) Drug self-administration. In: van Haaren F (ed) Methods in behavioral pharmacology. Elsevier, Amsterdam pp 257-300
145. Meisch RA, Stewart RB, Roache JD (1996) Studies of oral reinforcement by benzodiazepines in rhesus monkeys. In: Harris LS (ed) Problems of drug dependence, 1995. NIDA Research Monograph No. 162. NIH Publication No. 96-41 16. US Government Printing Office, Washington D.C., p 243
146. Mellinger GD, Balter, MB, Uhlenhuth EH (1984a) Antianxiety agents: duration of use and characteristics of users in the U.S.A. Curr Med Res Opin 8[Suppl. 4]: 21-36
147. Mellinger GD, Balter, MB, Uhlenhuth EH (1984b) Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 251: 375-379
148. Mello NK (1989) Drug self-administration procedures: alcohol and marijuana. In: Fischman MW, Mello NK (eds) Testing for abuse liability of drugs. NIDA Research Monograph No. 92, DHHS Publication No (ADM) 89-1613. US Government Printing Office, Washington D.C., pp 147-170
149. Mitchelson M, Davidson J, Hawks D, Hitchens L, Malone S (1970) Sedative abuse by heroin addicts. Lancet i: 606-607
150. Monane M, Glynn RJ, Avorn J (1996) Pharmacoepidemiology and drug utilization. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin Pharmacol Ther 59: 83-92
151. Moodley P, Golombok S, Shrine PH, Lader M (1993) Computed axial brain tomograms in long-term benzodiazepine users. Psychiatry Res 48: 135-144
152. Mueller TI, Goldenberg IM, Gordon AL, Keller MB, Warshaw MG (1996) Benzodiazepine use in anxiety disordered patients with and without a history of alcoholism. J Clin Psychiaty 57: 83-89
153. Mumford GK, Rush CR, Griffiths RR (1995a) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272: 570-580
154. Mumford GK, Rush CR, Griffiths RR (1995b) Alprazolam and DN-2327 (Pazinaclone) in humans: psychomotor. memory, subjective, and reinforcing effects. Exp Clin Psychopharmacol 3: 39-48
155. Mumford GK, Evans SM, Fleishaker JC, Griffiths RR (1995c) Alprazolam absorption kinetics affects abuse liability. Clin Pharmacol Ther 57: 356-365
156. Mützell S, Tibblin G (1989) High alcohol consumption, liver toxic drugs and brain damage - a population study. Upsala J Med Sci 94: 305-315
157. Myers AH, Baker SP, Van Natta ML, Abbey H, Robinson EG (1991) Risk factors associated with falls and injuries among elderly institutionalized persons. Am J Epidemiol 133: 1179-1190
158. Nader MA, Winger G, Woods JH, Wool verton WL (1991) Discriminative and reinforcing effects of brotizolam in rhesus monkeys. Psychopharmacology 103: 166-171
159. Naruse T, Asami T (1987) Intravenous self-administration of diazepam in rats. Eur J Pharmacol 135: 365-373
160. National Institutes of Health (1984) Drugs and insomnia. Consensus Development Conference Summary, Bethesda, Md. 4: 1-19
161. National Institute on Drug Abuse. Press Office (1995) 1995 "Monitoring the future" survey: tobacco, alcohol, and illicit drug use among youth study. HHS News, December 15, 1995
162. Navaratnam V, Foong K (1990) Opiate dependence - the role of benzodiazepines. Curr Med Res Opin 11: 620-630
163. Nelson LR, Potthoff AD, Ellison GD (1983) Increased consumption of diazepam during continuous amphetamine administration. Pharmacol Biochem Behav 18: 863-865
164. Oster G, Huse DM, Adams SF, Imbimbo J, Russell MW (1990) Benzodiazepine tranquilizers and the risk of accidental injury. Am J Public Health 80: 1467-1470
165. Perera KMH, Powell T, Jenner FA (1987) Computerized axial tomographic studies following long-term use of benzodiazepines. Psychol Med 17: 775-777
166. Pilotto R, Singer G, Overstreet D (1984) Self-injection of diazepam in naive rats: effects of dose, schedule and blockade of different receptors. Psychopharmacology 84: 174-177
167. Poser W, Poser S, Roscher D, Argyrakis A (1983) Do benzodiazepines cause cerebral atrophy? Lancet 8326: 715
168. Preston KL, Griffiths RR, Stitzer ML, Bigelow GE, Liebson IA (1984) Diazepam and methadone interactions in methadone maintenance. Clin Pharmacol Ther 36: 534-541
169. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316: 363-369
170. Ray WA, Griffin MR, Downey W (1989) Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 262: 3303-3307
171. Ray WA, Fought RL, Decker MD (1992a) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136: 873-883
172. Ray WA, Gurwitz J, Decker MD, Kennedy DL (1992b) Medications and the safety of the older driver: is there a basis for concern? Hum Fact 34: 33-47
173. Reddy S, Patt RB (1994) The benzodiazepines as adjuvant analgesics. J Pain Symptom Management 9: 510-514
174. Rickels K (1990) Buspirone in clinical practice. J Clin Psychiatr 51 [9, Suppl]: 51-54
175. Rickels K, Schweizer E, Case G, Greenblatt DJ (1990) Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry 47: 899-907
176. Rickels K, Case WG, Schweizer E, Garcia-Espana F, Fridman R (1991) Long-term benzodiazepine users 3 years after participation in a discontinuation program. Am J Psychiatry 148: 757-761
177. Roache JD, Griffiths RR (1985) Comparison of triazolam and pentobarbital: Performance impairment, subjective effects and abuse liability. J Pharmacol Exp Ther 234: 120-133
178. Roache JD, Griffiths RR (1989) Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration. Psychopharmacology 99: 309-315
179. Roache JD, Meisch RA, Henningfield JE, Jaffe JH, Klein S, Sampson A (1995) Reinforcing effects of triazolam in sedative abusers: correlation of drug liking and self-administration measures. Pharmacol Biochem Behav 50: 171-179
180. Roache JD, Stanley MA, Creson DL, Meisch RA, Shah NN (1996) Diazepam reinforcement in anxious patients. Exp Clin Psychopharmacol 4: 308-314
181. Roache JD, Stanley MA, Creson DR, Shah NN, Meisch RA (1997) Alprazolam-reinforced self-medication behavior in out-patients with anxiety. Drug Alcohol Depend (in press)
182. Roberge RF, Genest A, Beauchemin J-P, Parent M (1995) Potentially inappropriate prescribing of benzodiazepines to elderly nursing home patients. Can Fam Physician 41: 800-805
183. Roehrs T, Merlotti L, Zorick F, Roth T (1992) Rebound insomnia and hypnotic self administration. Psychopharmacology 107: 480-484
184. Roehrs T, Pedrosi B, Rosenthal L, Roth T (1996) Hypnotic self administration and dose escalation. Psychopharmacology 127: 150-154
185. Roehrs T, Pedrosi B, Rosenthal L, Zorick F, Roth T (1997) Hypnotic self administration: forced-choice versus single-choice. Psychopharmacology 133: 121-126
186. Romach M, Busto U, Somer G, Kaplan HL, Sellers E (1995) Clinical aspects of chronic use of alprazolam and lorazepam. Am J Psychiatry 152: 1161-1167
187. Ross HE (1993) Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction 88: 209-218
188. Ruben SM, Morrison CL (1992) Temazepam misuse in a group of injecting drug users. Br J Addict 87: 1387-1392
189. Ryynanen OP, Kivela SL, Honkanen R, Laippala P, Saano V (1993) Medications and chronic diseases as risk factors for falling injuries in the elderly. Scand J Soc Med 21: 264-271
190. Salinsky JV, Doré CJ (1987) Characteristics of long term benzodiazepine users in general practice. J R Coll Gen Pract 37: 202-204
191. Salzman C, Watsky E (1993) Rational prescribing of benzodiazepines. In: Hallström C (ed) Benzodiazepine dependence. Oxford University Press, Oxford, pp 13-33
192. Salzman C, Fisher J, Nobel K, Glassman R, Wolfson A, Kelley M (1992) Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Gen Psychiatry 7: 89-93
193. San L, Tato J, Torrens M, Castillo C, Farré M, Cami J (1993a) Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification. Drug Alcohol Depend 32: 281-286
194. San L, Torrens M, Castillo C, Porta M, de la Torre R (1993b) Consumption of buprenorphrine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990. Addiction 88: 1341-1349
195. Sanger DJ (1977) Schedule-induced drinking of chlordiazepoxide solutions by rats. Pharmacol Biochem Behav 7: 1-6
196. Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994) Recent developments in the behavioral pharmacology of benzodiazepine (w) receptors: evidence for the functional significance of receptor subtypes. Neurosci Biobehav Rev 18: 355-372
197. Sannerud CA, Ator NA, Griffiths RR (1992) Behavioral pharmacology of abecarnil in baboons: self-injection, drug discrimination and physical dependence. Behav Pharmacol 3: 507-516
198. Schmauss C, Krieg J-C (1987) Enlargement of cerebrospinal fluid spaces in long-term benzodiazepine abusers. Psychol Med 17: 869-873
199. Schweizer E, Case WG, Rickeis K (1989) Benzodiazepine dependence and withdrawal in elderly patients. Am J Psychiatry 146: 529-531
200. Schweizer E, Rickels K, Case WG, Greenblatt DJ (1990) Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Arch Gen Psychiatry 47: 908-915
201. Schweizer E, Rickels K, Weiss S, Zavodnick S (1993) Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Arch Gen Psychiatry 50: 51-60
202. Seivewright N, Dougal W (1993) Withdrawal symptoms from high dose benzodiazepines in poly drug users. Drug Alcohol Depend 32: 15-23
203. Seivewright N, Donmall M, Daly C (1993) Benzodiazepines in the illicit drugs scene: the UK picture and some treatment dilemmas. Int J Drug Policy 4: 42-48
204. Shorr RI, Bauwens SF (1992) Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians. Am J Med 93: 78-82
205. Shorr RI, Robin DW (1994) Rational use of benzodiazepines in the elderly. Drugs Aging 4: 9-20
206. Shorr RI, Bauwens SF, Landefeld CS (1990) Failure to limit quantities of benzodiazepine hypnotic drugs for outpatients: placing the elderly at risk. Am J Med 89: 725-732
207. Silverman K, Kirby KC, Griffiths RR (1994) Modulation of drug reinforcement by behavioral requirements following drug ingestion. Psychopharmacology 114: 243-247
208. Smith DE, Marks J (1985) Abuse and dependency: an international perspective. In: Smith DE, Wesson DR (eds) The benzodiazepines - current standards for medical practice. MTP Press, Lancaster, pp 179-199
209. Sobel KG, McCart GM (1983) Drug use and accidental falls in an intermediate care facility. Drug Intell Clin Pharm 17: 539-542
210. Sorock GS, Shimkin EE (1988) Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Arch Int Med 148: 2441-2444
211. Stewart RB, May FE, Moore MT, Hale WE (1989) Changing patterns of psychotropic drug use in the elderly: a five-year update. DICP. Ann Pharmacother 23: 610-613
212. Stewart RB, Lemaire GA, Roache JD, Meisch RA (1994a) Establishing benzodiazepines as oral reinforcers: midazolum and diazepam self-administration in rhesus monkeys. J Pharmacol Exp Ther 271:200-211
213. Stewart RB, Marks RG, Padgett PD, Hale WE (1994b) Benzodiazepine use in an ambulatory elderly population: a 14-year overview. Clin Ther 16: 118-124
214. Strang J, Seivewright N, Farrell M (1992) Intravenous and other novel abuses of benzodiazepines: the opening of Pandora's box? Br J Addict 87: 1373-1375
215. Strang J, Seivewright N, Farrell M (1993) Oral and IV abuse of benzodiazepines. In: Hallström C (ed) Benzodiazepine dependence. Oxford University Press, Oxford, pp 128-142
216. Strang J, Griffiths P, Abbey J, Gossop M (1994) Survey of use of injected benzodiazepines among drug users in Britain. BMJ 308: 1082
217. Stolerman IP, Kumar R, Steinberg H (1971) Development of morphine dependence in rats: lack of effect of previous ingestion of other drugs. Psychopharmacologia 20: 21-36
218. Szostak C, Finlay JM, Fibiger HC (1987) Intravenous self-administration of the short-acting benzodiazepine miduzolum in the rat. Neuropharmacology 26: 1673-1676
219. Tata PR, Rollings J, Collins M, Pickering A, Jacobson RR (1994) Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychol Med 24: 203-213
220. Thomson M, Smith WA (1995) Prescribing benzodiazepines for noninstitutionalized elderly. Can Fam Phys 41: 792-798
221. Tönne U, Hiltunen AJ, Vikander B, Engelbrektsson K, Bergman H, Bergman I, Leifman H, Borg S (1995) Neuropsychological changes during steady-state drug use. withdrawal and abstinence in primary benzodiazepine-dependent patients. Acta Psychiatr Stand 91: 299-304
222. Troisi JR II, Critchfield TS, Griffiths RR (1993) Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice. Behav Pharmacol 4: 217-230
223. Uhde TW, Kellner CH (1987) Cerebral ventricular size in panic-disorder. J Affect Disord 12: 175-178
224. Vocci FJ Jr (1989) The necessity and utility of abuse liability evaluations in human subjects: the FDA perspective. In: Fischman MW, Mello NK (eds) Testing for abuse liability of drugs. NIDA Research Monograph No. 92, DHHS Publication No (ADM) 89-1613. US Government Printing Office, Washington D.C., pp 7-20
225. Walton NY, Deutsch JA (1978) Self-administration of diazepam by the rat. Behav Biol 24: 533-538
226. Weerts EM, Kaminsky BJ, Griffiths RR (1997) Stable low-rate midazolam self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Psychopharmacology (in press)
227. Williams H, Oyefeso A, Ghodse AH (1996) Benzodiazepine misuse and dependence among opiate addicts in treatment. Irish J Psychol Med 13:62-64
228. Winger G, Stitzer ML, Woods JH (1975) Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. J Pharmacol Exp Ther 195: 505-514
229. Winger G, Woods JH, Patrick GA, Powell LJ, Harris LS, Nader MA, Woolverton WL (1992) Progress report from the testing program for stimulant and depressant drugs (1991) In: Harris LS (ed) Problems of drug dependence, 1991. NIDA Research Monograph No. 119, DHHS Publication No (ADM) 92-1888. US Government Printing Office, Washington, D.C., pp 625-639
230. Wiseman SM, Spencer-Peet J (1985) Prescribing for alcoholics - a survey of drugs taken prior to admission to an alcoholism unit. Practitioner 229: 88-89
231. Wolf B, Iguchi MY, Griffiths RR (1990) Sedative/tranquilizer use and abuse in alcoholics currently in outpatient treatment: incidence, pattern and preference. In: Harris LS (ed) Problems of drug dependence, 1989. NIDA Research Monograph No. 95. NIDA Research Monograph No. 95, DHHS Publication No (ADM) 90-1663. US Government Printing Office, Washington, D.C., pp 376-377
232. Wolf G, Jacquet Y, Carol M (1978) Test for oral and postingestional factors mediating differential acceptability of morphine, methamphetamine, and chlordiazepoxide drinking solutions. Psychopharmacology 60: 101-102
233. Wolffgramm J, Heyne A (1991) Social behavior, dominance, and social deprivation of rats determine drug choice. Pharmacol Biochem Behav 38: 389-399
234. Woods JH, Winger G (1995) Current benzodiazepine issues. Psychopharmacology 118: 107-115
235. Woods JH, Ikomi FI, Winger G (1971) The reinforcing properties of ethanol. In: Roach MK, Mclsaac WN, Creaven PJ (eds) Biological aspects of alcoholism. University of Texas Press, Austin, pp 371-388
236. Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39: 251-419
237. Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44: 151-347
238. Woolverton WL, Schuster CR (1983) Intragastric self-administration in rhesus monkeys under limited access conditions: methodological studies. J Pharmacol Methods 10: 93-106
239. World Health Organization (1995) WHO expert committee on drug dependence, twenty-ninth report. World Health Organization, Geneva
240. Yanagita T (1983) Dependence potential of zopiclone studied in monkeys. Pharmacology 27[Suppl 2]: 216-227
241. Yanagita T (1985) Dependence potential of the benzodiazepines: use of animal models for assessment. Clin Neuropharmacol 8[Suppl 1]: S118-S122
242. Yanagita T (1987) Prediction of abuse liability from animals studies. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York, pp 189-198
243. Yanagita T, Kiyohara H (1976) Dependence potential of ID-540 tested in rhesus monkeys. CIEA Preclinical Reports 2: 187-193
244. Yanagita T, Takahashi S (1973) Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther 185: 307-316
245. Yanagita T, Oinuma N, Takahashi S (1975a) Drug dependence potential of Sch 12041 evaluated in the rhesus monkey. CIEA Preclinical Reports 1: 231-235
246. Yanagita T, Takahashi S, Ito Y, Miyasato K (1975b) Drug dependence potential of prazepam evaluated in the rhesus monkey. CIEA Preclinical Reports 1: 257-262
247. Yanagita T, Takahashi S, Nakanishi H, Oinuma N (1975c) Drug dependence potential of cloxazolazepam evaluated in the rhesus monkey. CIEA Preclinical Reports 1: 223-230
248. Yanagita T, Takahashi S, Oinuma N (1975d) Drug dependence liability of S-1530 evaluated in the rhesus monkey. CIEA Preclinical Reports 1: 151-155
249. Yanagita T, Takahashi S, Oinuma N (1975e) Drug dependence potential of lorazepam (WY 4036) evaluated in the rhesus monkey. CIEA Preclinical Reports 1: 1-4
250. Yanagita T, Takahashi S, Sei M (1976) Drug dependence potential of estazolam tested in the rhesus monkey. CIEA Preclinical Reports 2: 35-39
251. Yanagita T, Miyasato K, Kiyohara H (1977a) Drug dependence potential of triazolam tested in rhesus monkeys. CIEA Preclinical Reports 3: 1-7
252. Yanagita T, Miyasato K, Takahashi S, Kiyohara H (1977b) Dependence potential of dipotassium clorazepate tested in rhesus monkeys. CIEA Preclinical Reports 3: 67-73
253. Yanagita T, Oinuma N, Nakanishi H (1981a) Drug dependence potential of clonazepam tested in the rhesus monkeys. CIEA Preclinical Reports 7: 29-35
254. Yanagita T, Kato S, Miyasato K (1981b) Dependence potential of flunitrazepam tested in rhesus monkeys. CIEA Preclinical Reports 7: 37-42
255. Yanagita T, Wakasa Y, Kato S (1981c) Dependence potential of alprazolam tested in rhesus monkeys. CIEA Preclinical Reports 7: 91-99
256. Yanagita T, Wakasa Y, Sei M (1981d) Dependence potential of clobazam tested in rhesus monkeys. CIEA Preclinical Reports 7: 115-122
257. Yanagita T, Kato S, Mikami M (1985) Dependence potential of lormetazepam studied in rhesus monkeys. CIEA Preclinical Reports 11: 21-31
258. Yanaura S, Tagashira E (1975) Dependence on and preference for morphine in naive and morphine-experienced rats (II): comparison of prefererence for morphine, phenobarbital and diazepam in naive and drug-dependent rats. Folia Pharmacol Japon 71: 285-294